ArticleMolecular therapy. Methods & clinical development2024

DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome.

Cole M Pugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.